Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Burger

Showing results (201-210 of 337) with videos related to

Pageof 34
Sort By:
Antiviral Therapy|February 7, 2009
Pharmacokinetics of lopinavir in HIV type-1-infected children taking the new tablet formulation once dailyMichiel van der Flier, Gwenda Verweel, Linda C van der Knaap, et al.
Cancer Chemotherapy and Pharmacology|December 20, 2019
A limited sampling schedule to estimate individual pharmacokinetics of pemetrexed in patients with varying renal functionsNikki de Rouw, Sabine Visser, Stijn L W Koolen, et al.
AIDS (London, England)|June 17, 2005
Pharmacokinetics of once-daily lopinavir/ritonavir and the influence of dose modificationsCharles J L la Porte, Emile F Schippers, Marchina E van der Ende, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 27, 2011
Neither branded nor generic lopinavir/ritonavir produces adequate lopinavir concentrations at a reduced dose of 200/50 mg twice dailyReshmie A Ramautarsing, Jasper van der Lugt, Meena Gorowara, et al.
AIDS (London, England)|April 9, 2009
Clinical experience with the combined use of lopinavir/ritonavir and rifampicinRafaëlla Fa L'homme, Hanneke M J Nijland, Luuk Gras, et al.
British Journal of Clinical Pharmacology|October 26, 2017
Parenteral bilirubin in healthy volunteers: a reintroduction in translational researchDouwe Dekker, Mirrin J Dorresteijn, Marieke E B Welzen, et al.
Antimicrobial Agents and Chemotherapy|September 12, 2007
Interaction study of the combined use of paroxetine and fosamprenavir-ritonavir in healthy subjectsManon J van der Lee, Audrey A M Blenke, Gerard A Rongen, et al.
Therapeutic Drug Monitoring|September 28, 2007
Semen quality and drug concentrations in seminal plasma of patients using a didanosine or didanosine plus tenofovir containing antiretroviral regimenSelwyn H Lowe, Elisabeth van Leeuwen, Jacqueline A H Droste, et al.
The Pediatric Infectious Disease Journal|July 21, 2011
A twice daily posaconazole dosing algorithm for children with chronic granulomatous diseaseMarieke E B Welzen, Roger J M Brüggemann, J Merlijn Van Den Berg, et al.
Drug Metabolism Reviews|August 1, 2006
Possible drug-metabolism interactions of medicinal herbs with antiretroviral agentsCarolien J P van den Bout-van den Beukel, Peter P Koopmans, André J A M van der Ven, et al.
Pageof 34

Showing results (201-210 of 337) with videos related to

Sort By:
Pageof 34
Antiviral Therapy|February 7, 2009
Pharmacokinetics of lopinavir in HIV type-1-infected children taking the new tablet formulation once dailyMichiel van der Flier, Gwenda Verweel, Linda C van der Knaap, et al.
Cancer Chemotherapy and Pharmacology|December 20, 2019
A limited sampling schedule to estimate individual pharmacokinetics of pemetrexed in patients with varying renal functionsNikki de Rouw, Sabine Visser, Stijn L W Koolen, et al.
AIDS (London, England)|June 17, 2005
Pharmacokinetics of once-daily lopinavir/ritonavir and the influence of dose modificationsCharles J L la Porte, Emile F Schippers, Marchina E van der Ende, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 27, 2011
Neither branded nor generic lopinavir/ritonavir produces adequate lopinavir concentrations at a reduced dose of 200/50 mg twice dailyReshmie A Ramautarsing, Jasper van der Lugt, Meena Gorowara, et al.
AIDS (London, England)|April 9, 2009
Clinical experience with the combined use of lopinavir/ritonavir and rifampicinRafaëlla Fa L'homme, Hanneke M J Nijland, Luuk Gras, et al.
British Journal of Clinical Pharmacology|October 26, 2017
Parenteral bilirubin in healthy volunteers: a reintroduction in translational researchDouwe Dekker, Mirrin J Dorresteijn, Marieke E B Welzen, et al.
Antimicrobial Agents and Chemotherapy|September 12, 2007
Interaction study of the combined use of paroxetine and fosamprenavir-ritonavir in healthy subjectsManon J van der Lee, Audrey A M Blenke, Gerard A Rongen, et al.
Therapeutic Drug Monitoring|September 28, 2007
Semen quality and drug concentrations in seminal plasma of patients using a didanosine or didanosine plus tenofovir containing antiretroviral regimenSelwyn H Lowe, Elisabeth van Leeuwen, Jacqueline A H Droste, et al.
The Pediatric Infectious Disease Journal|July 21, 2011
A twice daily posaconazole dosing algorithm for children with chronic granulomatous diseaseMarieke E B Welzen, Roger J M Brüggemann, J Merlijn Van Den Berg, et al.
Drug Metabolism Reviews|August 1, 2006
Possible drug-metabolism interactions of medicinal herbs with antiretroviral agentsCarolien J P van den Bout-van den Beukel, Peter P Koopmans, André J A M van der Ven, et al.
Pageof 34